Immunotherapy can dramatically improve outcomes for many cancers, but for about 70% of cancer patients, these therapies don’t work. Researchers at the University of Michigan Health Rogel Cancer Center recently discovered a key reason. Weiping Zou, M.D., Ph.D., director of the Center of Excellence for Cancer Immunology and Immunotherapy at the Rogel Cancer Center, explores key findings from his team.
